Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis

This study has been completed.
Information provided by:
Catalysis SL Identifier:
First received: August 27, 2009
Last updated: May 6, 2011
Last verified: May 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)